Bladder & bowel care for healthcare professionals

NHS Improvement has issued a Patient Safety Alert requiring all NHS healthcare providers treating patients with neurogenic bowel dysfunction to ensure that policies, procedures and appropriately trained staff are in place to meet patient needs by 25th January 2019.

Bowel Interest Group, 2020. Cost of Constipation 3^rd Edtion. Available here:https://bowelinterestgroup.co.uk/resources/cost-of-constipation-report-2020/

Peristeen should be considered when:

First-line treatments (e.g. laxatives, diet changes) fail to provide sufficient relief

The patient is within the principle bowel dysfunction patient groups: neurogenic, functional, paediatric

Patient assessments have been conducted and the patient is engaged

Headline

Bladder & Bowel Care for Healthcare Professionals

Product solutions

Education

Clinical evidence

NHS Patient Safety Alert on Bowel Care Pathways

The Cost of Constipation

Peristeen should be considered when:

Peristeen®

Regulated by the Care Quality Commission (CQC)

Thank you